Regeneron and Trump Agree to Lower Drug Prices and Offer Hearing Loss Treatment
Regeneron Pharmaceuticals announced a historic agreement with U.S. President Donald Trump to reduce prices on certain medications in the United States. The deal also includes providing a new hearing loss treatment free of charge to eligible patients, reflecting ongoing efforts by the U.S. government to lower drug costs.